The Efficacy of Indoximod upon Stimulation with Pro-inflammatory Cytokines in Triple-Negative Breast Cancer Cells

Scientists determined the effects of indoximod as an indoleamine 2,3-dioxygenase inhibitor on triple-negative breast cancer and to assess the link between the efficacy of indoximod and IFN-γ or TNF-α stimulation.